Strategy Inc. helped us to get a handle on an emerging therapeutic solution that provides a complete paradigm shift – a revolutionary, not evolutionary approach. A Voice of the Customer with global leaders confirmed several of our assumptions, and also uncovered different priorities that will drive our strategy. In addition, several alternative opportunities for positioning were unearthed. I am pleased with the work performed by Strategy Inc. Jim Broderick MD, Partner, Morgenthaler Ventures, Boston, Massachusetts

Morgenthaler Ventures, founded 40 years ago, with $2.5B under management, including $450M in their current fund is located on Sand Hill Road in Menlo Park. Their Life Sciences division invests in Medical Devices, Biopharmaceuticals, Therapeutics and more.